123 related articles for article (PubMed ID: 2576866)
1. Efficacy of inactivated vaccine containing cyto-hemagglutinin against epidemic hemorrhagic fever in rabbits.
Zhu ZY; Tang HY; Li YJ; Weng JQ; Fu GM
Chin Med J (Engl); 1989 Aug; 102(8):602-5. PubMed ID: 2576866
[TBL] [Abstract][Full Text] [Related]
2. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to inactivated vaccine in people naturally infected with hantaviruses.
Lu Q; Zhu Z; Weng J
J Med Virol; 1996 Aug; 49(4):333-5. PubMed ID: 8877768
[TBL] [Abstract][Full Text] [Related]
4. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS).
Song G; Huang YC; Hang CS; Hao FY; Li DX; Zheng XL; Liu WM; Li SL; Huo ZW; Huei LJ
Vaccine; 1992; 10(4):214-6. PubMed ID: 1348595
[TBL] [Abstract][Full Text] [Related]
5. Protective Effectiveness of Inactivated Hantavirus Vaccine Against Hemorrhagic Fever With Renal Syndrome.
Jung J; Ko SJ; Oh HS; Moon SM; Song JW; Huh K
J Infect Dis; 2018 Apr; 217(9):1417-1420. PubMed ID: 29373686
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax).
Cho HW; Howard CR
Vaccine; 1999 Jun; 17(20-21):2569-75. PubMed ID: 10418904
[TBL] [Abstract][Full Text] [Related]
7. [Observational and experimental studies on relationship between domestic pigs and epidemic hemorrhagic fever investigation].
Zhang Y; Li X; Tang J
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):344-7. PubMed ID: 8697938
[TBL] [Abstract][Full Text] [Related]
8. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
Liu W; Xu X; Ruan Y; Weng S; Liu W; Zhou W; Dong G; Gu H; Zhu Z; Xu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
[TBL] [Abstract][Full Text] [Related]
9. [Real-time PCR assay development for the control of vaccine against hemorrhagic fever with renal syndrome].
Egorova MS; Kurashova SS; Ishmukhametov AA; Balovneva MV; Deviatkin AA; Safonova MV; Ozherelkov SV; Khapchaev YK; Balkina AS; Belyakova AV; Dzagurova TK; Tkachenko EA
Vopr Virusol; 2021 Mar; 66(1):65-73. PubMed ID: 33683067
[TBL] [Abstract][Full Text] [Related]
10. [Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination].
Chen H; Tang L; Luo Z; Zhang J; Zhang Z; Hu M; Weng J; Liu W; Zhao T; Liu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Oct; 21(5):347-8. PubMed ID: 11860813
[TBL] [Abstract][Full Text] [Related]
11. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome.
Yamanishi K; Tanishita O; Tamura M; Asada H; Kondo K; Takagi M; Yoshida I; Konobe T; Fukai K
Vaccine; 1988 Jun; 6(3):278-82. PubMed ID: 3138829
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation of the type of EHF antibodies by RPHI].
Li XF
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):238-40. PubMed ID: 2572325
[TBL] [Abstract][Full Text] [Related]
13. Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.
White A; Berman S; Lowenthal JP
Appl Microbiol; 1971 Nov; 22(5):909-13. PubMed ID: 5132097
[TBL] [Abstract][Full Text] [Related]
14. Antigenic difference between viral strains causing classical and mild types of epidemic hemorrhagic fever with renal syndrome in China.
Song G; Hang CS; Liao HX; Fu JL; Gao GZ; Qiu HL; Zhang QF
J Infect Dis; 1984 Dec; 150(6):889-94. PubMed ID: 6150062
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
[TBL] [Abstract][Full Text] [Related]
16. Review of an inactivated vaccine against hantaviruses.
Cho HW; Howard CR; Lee HW
Intervirology; 2002; 45(4-6):328-33. PubMed ID: 12602351
[TBL] [Abstract][Full Text] [Related]
17. [Leptotrombidium scutellare in transmission of epidemic hemorrhagic fever virus].
Wu G
Zhonghua Yi Xue Za Zhi; 1992 Aug; 72(8):481-3, 510. PubMed ID: 1363219
[TBL] [Abstract][Full Text] [Related]
18. Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses.
Swanepoel R; Struthers JK; McGillivray GM
Am J Trop Med Hyg; 1983 May; 32(3):610-7. PubMed ID: 6407347
[TBL] [Abstract][Full Text] [Related]
19. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
[TBL] [Abstract][Full Text] [Related]
20. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
